These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 36536233)

  • 21. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.
    Khan FH; Ahlberg CD; Chow CA; Shah DR; Koo BB
    J Neurol; 2017 Aug; 264(8):1634-1641. PubMed ID: 28236139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of dopamine receptor agonists in the treatment of restless legs syndrome.
    Happe S; Trenkwalder C
    CNS Drugs; 2004; 18(1):27-36. PubMed ID: 14731057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restless legs syndrome.
    Ekbom K; Ulfberg J
    J Intern Med; 2009 Nov; 266(5):419-31. PubMed ID: 19817966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The restless legs syndrome can be treated with dopamine agonists].
    Aramideh M; de Weerd AW
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2173-7. PubMed ID: 17061425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral restless legs affecting a phantom limb, treated with dopamine agonists.
    Skidmore FM; Drago V; Foster PS; Heilman KM
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):569-70. PubMed ID: 19372293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical primer on restless legs syndrome: what we know, and what we don't know.
    Sethi KD; Mehta SH
    Am J Manag Care; 2012 Aug; 18(5 Suppl):S83-8. PubMed ID: 23009275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restless legs syndrome: From clinic to personalized medicine.
    Chenini S; Barateau L; Dauvilliers Y
    Rev Neurol (Paris); 2023 Oct; 179(7):703-714. PubMed ID: 37689536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on the pathophysiology and genetics of restless legs syndrome.
    Trotti LM; Bhadriraju S; Rye DB
    Curr Neurol Neurosci Rep; 2008 Jul; 8(4):281-7. PubMed ID: 18590611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restless Legs Syndrome: Contemporary Diagnosis and Treatment.
    Gossard TR; Trotti LM; Videnovic A; St Louis EK
    Neurotherapeutics; 2021 Jan; 18(1):140-155. PubMed ID: 33880737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe restless legs syndrome in a family with Alport syndrome.
    Sparasci D; Rossinelli A; Ferri R; Cippà P; Rinaldi A; Manconi M
    BMC Nephrol; 2021 Jul; 22(1):249. PubMed ID: 34225668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of restless legs syndrome under the new concept: A review.
    Liu Z; Guan R; Pan L
    Medicine (Baltimore); 2022 Dec; 101(50):e32324. PubMed ID: 36550837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.
    Quiroz C; Gulyani S; Ruiqian W; Bonaventura J; Cutler R; Pearson V; Allen RP; Earley CJ; Mattson MP; Ferré S
    Neuropharmacology; 2016 Dec; 111():160-168. PubMed ID: 27600688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restless legs syndrome: a review of diagnosis and management in primary care.
    Bogan RK; Cheray JA
    Postgrad Med; 2013 May; 125(3):99-111. PubMed ID: 23748511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Utility of Opioids for Restless Legs Syndrome.
    Mackie SE; Winkelman JW
    Drugs; 2017 Aug; 77(12):1337-1344. PubMed ID: 28616844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restless legs syndrome in women: a review.
    Thomas K; Watson CB
    J Womens Health (Larchmt); 2008 Jun; 17(5):859-68. PubMed ID: 18537487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of restless legs syndrome.
    Ferini-Strambi L; Manconi M
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S65-70. PubMed ID: 20123560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.